These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17321620)

  • 1. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy.
    Salembier C; Lavagnini P; Nickers P; Mangili P; Rijnders A; Polo A; Venselaar J; Hoskin P;
    Radiother Oncol; 2007 Apr; 83(1):3-10. PubMed ID: 17321620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.
    Kovács G; Pötter R; Loch T; Hammer J; Kolkman-Deurloo IK; de la Rosette JJ; Bertermann H
    Radiother Oncol; 2005 Feb; 74(2):137-48. PubMed ID: 15734201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].
    Cosset JM; Hannoun-Lévi JM; Peiffert D; Delannes M; Pommier P; Pierrat N; Nickers P; Thomas L; Chauveinc L
    Cancer Radiother; 2013 Apr; 17(2):111-7. PubMed ID: 23478488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
    Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
    Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
    Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.
    Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C
    Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of Day 1 imaging following LDR prostate brachytherapy.
    Nobes JP; Laing R; Langley S
    Radiother Oncol; 2008 Feb; 86(2):288-9; author reply 289-90. PubMed ID: 17963906
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
    Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.
    Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
    Radiat Oncol; 2017 Dec; 12(1):192. PubMed ID: 29191234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-source genetic algorithm for determining optimal seed distributions for low-dose-rate prostate brachytherapy.
    McGeachy P; Madamesila J; Beauchamp A; Khan R
    Brachytherapy; 2015; 14(5):692-702. PubMed ID: 26023047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
    Miksys N; Vigneault E; Martin AG; Beaulieu L; Thomson RM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):606-615. PubMed ID: 28126308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing CTVs for permanent prostate brachytherapy.
    Oton CA; Blanco L; Oton LF; Moral S
    Clin Transl Oncol; 2015 May; 17(5):393-7. PubMed ID: 25351173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer.
    Ash D; Flynn A; Battermann J; de Reijke T; Lavagnini P; Blank L; ;
    Radiother Oncol; 2000 Dec; 57(3):315-21. PubMed ID: 11104892
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
    White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution.
    Rutten TP; Lawson JM; Marcu LG
    Phys Med; 2013 Nov; 29(6):662-9. PubMed ID: 22975428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
    Zilli T; Taussky D; Donath D; Le HP; Larouche RX; Béliveau-Nadeau D; Hervieux Y; Delouya G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e377-83. PubMed ID: 21514068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
    Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
    Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update.
    Hoskin PJ; Colombo A; Henry A; Niehoff P; Paulsen Hellebust T; Siebert FA; Kovacs G
    Radiother Oncol; 2013 Jun; 107(3):325-32. PubMed ID: 23773409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.